Early identification of potential threats is essential if a problem is to be nipped in the bud. Biocom S.A., the first industrial spin-off to emerge from France's Institut National de la Sante et de la Recherche Medicale (Inserm), is focusing on developing systems for the rapid and specific detection of cancer cells and bacteria.

Biocom is focusing on the agrifood industry, where quality control in dairy and meat production and processing is paramount, and on cancer diagnosis and therapy.